Stress management by benzodiazepines in septic shock and critical illness: mechanistic and clinical evidence supporting alternative sedative strategies
Cell Stress · 07.08.2026 · 10 · 64-73
DOI: 10.15698/cst2026.08.320 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Stress, online erschienen am 07.08.2026. Verfasst von Flavia Lambertucci und 6 weiteren Autor:innen. Beteiligte Einrichtung: Team "Metabolism, Cancer & Immunity", Équipe Labellisée par la Ligue Contre le Cancer, Centre de Recherche des Cordeliers, Inserm UMRS1138, Universit…. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Sepsis
Abstract (Originalsprache)
Critical care involves the management of organismal stress by sedation. Benzodiazepines remain widely used for anxiolysis and sedation in critical care, including in septic shock. Yet converging mechanistic, preclinical and clinical evidence suggests that benzodiazepines and the endogenous ligand of benzodiazepine-binding sites, the “endozepine” acyl-CoA binding protein/diazepam binding inhibitor (ACBP/DBI), may impair host immune defenses, exacerbate organ dysfunction and contribute to long-term morbidity after intensive care. A unifying framework is that benzodiazepines may accelerate “iatrogenic aging” by antagonizing adaptive stress responses (notably autophagy) and favoring cellular senescence, chronic inflammation, immunosuppression and neurocognitive perturbations. Here, we synthesize evidence supporting benzodiazepine avoidance in sepsis-heavy intensive care populations. We propose that replacing benzodiazepines with alternative sedative strategies may improve both short-term outcomes and long-term trajectories of post-sepsis disability. We hypothesize that post-intensive-care syndrome (PICS), including -as a specific case- post-sepsis syndrome (PSS), is caused by premature aging of the organism and that PICS/PSS might be attenuated by the avoidance of benzodiazepine administration during and after critical care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Team "Metabolism, Cancer & Immunity", Équipe Labellisée par la Ligue Contre le Cancer, Centre de Recherche des Cordeliers, Inserm UMRS1138, Université Paris Cité, Sorbonne Université, Paris, France.
- Université Paris Cité, INSERM, CNRS, Institut Necker Enfants Malades, Paris, France.
- Service de Microbiologie Clinique, AP-HP, Hôpital Necker Enfants Malades, Paris, France.
- AP-HP, Hôpital Louis Mourier, DMU ESPRIT, Service de Médecine Intensive Réanimation, Colombes, France.
- Université Paris Cité, INSERM UMR-S1151, CNRS UMR-S8253, Institut Necker Enfants Malades, Paris, France.
- Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France.
Zitieren
APA
Lambertucci, F., Skurnik, D., Roux, D., Arbibe, L., Bezu, L., Martins, I., & Kroemer, G. (2026). Stress management by benzodiazepines in septic shock and critical illness: mechanistic and clinical evidence supporting alternative sedative strategies. Cell Stress, 10, 64-73. https://doi.org/10.15698/cst2026.08.320
Vancouver
Lambertucci F, Skurnik D, Roux D, Arbibe L, Bezu L, Martins I, et al. Stress management by benzodiazepines in septic shock and critical illness: mechanistic and clinical evidence supporting alternative sedative strategies. Cell Stress. 2026;10:64-73. doi:10.15698/cst2026.08.320
BibTeX
@article{Lambertucci2026,
author = {Lambertucci, Flavia and Skurnik, David and Roux, Damien and Arbibe, Laurence and Bezu, Lucillia and Martins, Isabelle and Kroemer, Guido},
title = {Stress management by benzodiazepines in septic shock and critical illness: mechanistic and clinical evidence supporting alternative sedative strategies},
journal = {Cell Stress},
year = {2026},
volume = {10},
pages = {64--73},
doi = {10.15698/cst2026.08.320}
}
EUVIMED